ARTICLE
7 October 2021

J&J Talc Ruling Could Upend FDA Process, Ex-Head Tells SCOTUS

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Morrison & Foerster was mentioned in Bloomberg Law's coverage of a recent amicus brief filed by eight former Food and Drug Administration officials.
United States Mississippi Food, Drugs, Healthcare, Life Sciences

Morrison & Foerster was mentioned in Bloomberg Law's coverage of a recent amicus brief filed by eight former Food and Drug Administration (FDA) officials in the U.S. Supreme Court in Johnson & Johnson v. Mississippi.

The officials argue that a Mississippi court decision allowing a consumer suit that challenges Johnson & John's talc labeling threatens to "upend" the FDA's vital decision-making process and could jeopardize public health. Read a copy of the amicus brief.

Joe Palmore, Stacy Cline Amin, Adam Sorensen, and Zachary Fuchs are representing the eight FDA officials.

Read the full article (subscription required).

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More